Internal Medicine Residency

References

• Mounsey A, Brendle DC, Flowers K. Oral vs. Intramuscular Vitamin B12 for Treating Vitamin B12 Deficiency. Am Fam Physician. 2022 Jun;105(6):663-664. PMID: 35713630.
• Vidal-Alaball J, Butler CC, Cannings-John R, Goringe A, Hood K, McCaddon A, McDowell I, Papaioannou A. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004655. doi: 10.1002/14651858.CD004655.pub2. Update in: Cochrane Database Syst Rev. 2018 Mar 15;3:CD004655. PMID: 16034940; PMCID: PMC5112015.
• Vitamin B12 Deficiency As a Cause of Hemolytic Anemia. Abstract published at Hospital Medicine 2012, April 1- 4, San Diego, Calif. Abstract 97850 Journal of Hospital Medicine, Volume 7, Suppl 2.
• Washington Manual of Medical Therapeutics
• MKSAP

References

• Lori Ann Linkins , MD, Antonio L. Dans, MD, et al. Treatment and prevention of Heparin Induced Thrombocytopenia: a systematic review: anti thrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence based clinical practice guidelines. Chest. 2012;141 (2)(suppl): e495S e530s
• MacLean S, Mulla S, Akl EA, et al. Patient values and preferences in decision making for anti thrombotic therapy: a systematic review: anti  thrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence based clinical practice guidelines.  Chest. 2012;141 (2)(suppl):e1S-e23S
• Allyson M. Pishko , MD, Lori Ann Linkins , MD, et al. Diagnosis and Management of Heparin Induced Thrombocytopenia: A Pocket Guide for the clinician 2018
• UpToDate
• MKSAP 19

References

The American Cancer Society. About chronic lymphocytic leukemia. Cancer.org. Accessed 8/30/2022
University of Liverpool Covid-19 Drug Interactions Checker.
A Ralph, B Eperjesiovia, and A Stone, Pleural effusion as a rare presentation of T-Cell Prolymphocytic Leukemia (T-PLL). Pulmonary Manifestations of Systemic Disease. Chest Annual Meeting 2016.
D Catovsky and C Dearden. Treatment of T cell prolymphocytic leukemia. UpToDate.
L Gindi et al. Levels of expression of CD52 in normal and leukemic B and T cells: correleation with in vivo therapeutic responses to Campath-1H. Leuk Res. 1998;22(2):185.
H Kaseb, A Madan, R Killeen, and S Hozayen. T Cell Prolymphocytic Leukemia. StatPearls. Updated May 1 2022: Accessed August 24 2022.
M Gertz. Acute hyperviscosity: syndromes and management. Blood. Volume 32, Number 13, p 1379-1385.
M Lichtman and J Rowe. Hyperleukocytic leukemias: rheological, clinical and therapeutic considerations. Blood. 1982 Aug; 60(2): 279-283
D antwal et al. An unusual presentation of chronic lymphocytic leukemia. Avicenna J Med. 2017 Jul-Sep; 7(3): 133-136
N Singh et al. Leukostasis in chronic lymphocytic leukemia. Am J Case Rep 2020; 21: e924798
B Sing et al. COVID-19-induced hyperleucocytosis in chronic lymphocytic leukaemia. European Journal of Case Reports in Internal Medicine. 2021;8
M Baer et al. Chronic lymphocytic leukemia with hyperleukocytosis. Cancer. 56:2865-2869, 1985.
C Schiffer. Hyperleukocytisis and leukostatis in hematologic malignancies. UpToDate.
CDC Covid-19 Treatment Guidelines: Remdesivir.

References

• Mirrakhimov AE, Voore P, Khan M, Ali AM. Tumor lysis syndrome: A clinical review. World J Crit Care Med. 2015 May 4;4(2):130-8. doi: 10.5492/wjccm.v4.i2.130. PMID: 25938028; PMCID: PMC4411564.
• Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011 May 12;364(19):1844-54. doi: 10.1056/NEJMra0904569. Erratum in: N Engl J Med. 2018 Sep 13;379(11):1094. PMID: 21561350; PMCID: PMC3437249.
• Puri I, Sharma D, Gunturu KS, Ahmed AA. Diagnosis and management of tumor lysis syndrome. J Community Hosp Intern Med Perspect. 2020 Jun 14;10(3):269-272. doi: 10.1080/20009666.2020.1761185. PMID: 32850076; PMCID: PMC7426989.
• Washington Manual of Medical Therapeutics 36th Edition
• Pession A, Melchionda F, Castellini C. Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase). Biologics. 2008;2(1):129-141. doi:10.2147/btt.s1522  Figure 3
• Onco-Nephrology: Tumor Lysis Syndrome August 2012 Clinical Journal of the American Society of Nephrology 7(10):1730-9 Figure 1. https://www.researchgate.net/figure/Cairo-Bishop-classification-of-tumor-lysis-syndrome-in-adults_tbl1_230645601
• UpToDate
• MKSAP19